TITLE

The effect of subthalamic nucleus stimulation on kinaesthesia in Parkinson's disease

AUTHOR(S)
Maschke, M.; Tuite, P. J.; Pickett, K.; Wächter, T.; Konczak, J.; Wächter, T
PUB. DATE
April 2005
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Apr2005, Vol. 76 Issue 4, p569
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Background: Parkinson's disease is accompanied by deficits in passive motion and limb position sense.Objective: To investigate whether deep brain stimulation of the subthalamic nucleus (STN-DBS) reverses these proprioceptive deficits.Methods and Results: A passive movement task was applied to nine patients with Parkinson's disease and bilateral chronic STN-DBS and to seven controls. Thresholds for 75% correct responses were 0.9 degrees for controls, 2.5 degrees for Parkinson's disease patients when stimulation was OFF, and 2.0 degrees when stimulation was ON.Conclusions: STN-DBS improves kinaesthesic deficits in Parkinson's disease, but does not lead to a full recovery of proprioceptive function.
ACCESSION #
16896787

 

Related Articles

  • Lasker Award Winner Alim Louis Benabid.  // Nature Medicine;Oct2014, Vol. 20 Issue 10, p1121 

    An interview with chairman Alim Louis Benabid of the board at Clinatec Institute in Grenoble, France who received the 2014 Lasker-DeBakey Clinical Medical Research Award is presented. Topics discussed include how his interest in physics and medicine led to the discovery of deep brain stimulation...

  • Non-Human Primate: An Essential Building Brick in the Discovery of the Subthalamic Deep Brain Stimulation Therapy. Benazzouz, Abdelhamid; Gross, Christian; Bioulac, Bernard // Frontiers in Aging Neuroscience;1/12/2016, p1 

    The article ficuses on the role of the non-human promates in neuroscience which led to the discovery of the application of high frequency stimulation and deep brain stimulation in patients with neurological conditions. Several developments in neuroscience are cited including the use of ablative...

  • The Subthalamic Nucleus, Limbic Function, and Impulse Control. Rossi, P.; Gunduz, Aysegul; Okun, Michael // Neuropsychology Review;Dec2015, Vol. 25 Issue 4, p398 

    It has been well documented that deep brain stimulation (DBS) of the subthalamic nucleus (STN) to address some of the disabling motor symptoms of Parkinson's disease (PD) can evoke unintended effects, especially on non-motor behavior. This observation has catalyzed more than a decade of research...

  • Short circuit. Ridgway, Andy // New Scientist;10/24/2015, Vol. 228 Issue 3044, p1 

    The article discusses the treatment of diseases through what is known as deep brain stimulation, commenting on clinical trials of the treatment in neuroscience. An overview of the use of deep brain stimulation to treat Parkinson's diseases and mental depression is provided.The neurosurgeon Dirk...

  • Oscillations in pedunculopontine nucleus in Parkinson's disease and its relationship with deep brain stimulation. Min Li; Wangming Zhang // Frontiers in Neural Circuits;Sep2015, Vol. 9, p1 

    The recent development of deep brain stimulation (DBS) of the pedunculopontine nucleus (PPN) for the treatment of parkinsonian patients, particularly those in advanced stages with axial symptoms, has ignited interest into the study of this brain nucleus. In contrast to the extensively studied...

  • Deep brain stimulation for Parkinson's disease prior to L-dopa treatment: A case report. Servello, Domenico; Saleh, Christian; Bona, Alberto R.; Zekaj, Edvin; Zanaboni, Carlotta; Porta, Mauro // Surgical Neurology International;2016 Supplement, Vol. 7, pS827 

    Background: Leva-dopa (L-dopa) is the gold-standard treatment for Parkinson's disease (PD). Deep brain stimulation is generally reserved for patients who become refractory to l-dopa treatment. Case Description: We present a male patient with a 9-year course of PD who at 53 years of age preferred...

  • Sequence of electrode implantation and outcome of deep brain stimulation for Parkinson's disease. Sammartino, Francesco; Krishna, Vibhor; King, Nicolas Kon Kam; Bruno, Veronica; Kalia, Suneil; Hodaie, Mojgan; Marras, Connie; Lozano, Andres M.; Fasano, Alfonso // Journal of Neurology, Neurosurgery & Psychiatry;Aug2016, Vol. 87 Issue 8, p859 

    Introduction: The effect of the variability of electrode placement on outcomes after bilateral deep brain stimulation of subthalamic nucleus has not been sufficiently studied, especially with respect to the sequence of hemisphere implantation.Methodology: We...

  • New treatment improves symptoms of Parkinson's disease. Mayor, Susan // BMJ: British Medical Journal (International Edition);4/27/2002, Vol. 324 Issue 7344, p997 

    Reports on promising preliminary results of tests of a treatment for Parkinson's disease in which a growth factor is pumped directly into dopamine deficient areas of the brain. Details of the study which was conducted by the Frenchay Hospital in Bristol, England; Improvement in the symptoms of...

  • Pharmacological treatment of Parkinson’s disease: life beyond dopamine D2/D3 receptors? Linazasoro, G.; Van Blercom, N.; Ugedo, L.; Ruiz Ortega, J. A. // Journal of Neural Transmission;Mar2008, Vol. 115 Issue 3, p431 

    Parkinson’s disease (PD) is a multisystemic disorder in which several neurotransmitters other than dopamine are affected. Drugs acting on non-dopaminergic systems are envisaged as promising agents to treat PD and levodopa-induced dyskinesias (LID). However, compounds targeting glutamate,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics